247 related articles for article (PubMed ID: 22984594)
1. Clues to occult cancer in patients with ischemic stroke.
Kim SJ; Park JH; Lee MJ; Park YG; Ahn MJ; Bang OY
PLoS One; 2012; 7(9):e44959. PubMed ID: 22984594
[TBL] [Abstract][Full Text] [Related]
2. Ability of the number of territories involved on DWI-MRI to predict occult systemic malignancy in cryptogenic stroke patients.
Guo L; Wang L; Liu W
J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104823. PubMed ID: 32362555
[TBL] [Abstract][Full Text] [Related]
3. D-dimer >2.785 μg/ml and multiple infarcts ≥3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients.
Wang JY; Zhang GJ; Zhuo SX; Wang K; Hu XP; Zhang H; Qu LD
Neurol Res; 2018 Nov; 40(11):948-954. PubMed ID: 30317943
[TBL] [Abstract][Full Text] [Related]
4. Plasma D-dimer levels and ischaemic lesions in multiple vascular regions can predict occult cancer in patients with cryptogenic stroke.
Gon Y; Sakaguchi M; Takasugi J; Kawano T; Kanki H; Watanabe A; Oyama N; Terasaki Y; Sasaki T; Mochizuki H
Eur J Neurol; 2017 Mar; 24(3):503-508. PubMed ID: 28026909
[TBL] [Abstract][Full Text] [Related]
5. Voxel-Based Lesion Mapping of Cryptogenic Stroke in Patients with Advanced Cancer: A Detailed Magnetic Resonance Imaging Analysis of Distribution Pattern.
Achiha T; Takagaki M; Oe H; Sakai M; Matsui H; Nakanishi K; Ozaki T; Fujimoto Y; Yoshimine T; Nakanishi K; Kinoshita M
J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1521-1527. PubMed ID: 28363514
[TBL] [Abstract][Full Text] [Related]
6. D-dimer as a predictor of early neurologic deterioration in cryptogenic stroke with active cancer.
Nam KW; Kim CK; Kim TJ; An SJ; Demchuk AM; Kim Y; Jung S; Han MK; Ko SB; Yoon BW
Eur J Neurol; 2017 Jan; 24(1):205-211. PubMed ID: 27766716
[TBL] [Abstract][Full Text] [Related]
7. D-dimer and Body CT to Identify Occult Malignancy in Acute Ischemic Stroke.
Rosenberg J; Do D; Cucchiara B; Messé SR
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105366. PubMed ID: 33039769
[TBL] [Abstract][Full Text] [Related]
8. D-dimer and C-reactive Protein as Potential Biomarkers for Diagnosis of Trousseau's Syndrome in Patients with Cerebral Embolism.
Tsushima M; Metoki N; Hagii J; Saito S; Shiroto H; Yasujima M; Kato T; Kudo N; Toyama Y; Yokono Y; Nozaka M; Kawamura Y; Nakata M; Tomita H
J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104534. PubMed ID: 31810721
[TBL] [Abstract][Full Text] [Related]
9. Ischemic stroke in patients with cancer: is it different from usual strokes?
Lee EJ; Nah HW; Kwon JY; Kang DW; Kwon SU; Kim JS
Int J Stroke; 2014 Jun; 9(4):406-12. PubMed ID: 23981525
[TBL] [Abstract][Full Text] [Related]
10. Active Cancer and Elevated D-Dimer Are Risk Factors for In-Hospital Ischemic Stroke.
Yamaguchi I; Kanematsu Y; Shimada K; Korai M; Miyamoto T; Shikata E; Yamaguchi T; Yamamoto N; Yamamoto Y; Kitazato KT; Okayama Y; Takagi Y
Cerebrovasc Dis Extra; 2019; 9(3):129-138. PubMed ID: 31760390
[TBL] [Abstract][Full Text] [Related]
11. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea.
Kim SG; Hong JM; Kim HY; Lee J; Chung PW; Park KY; Kim GM; Lee KH; Chung CS; Bang OY
Stroke; 2010 Apr; 41(4):798-801. PubMed ID: 20150545
[TBL] [Abstract][Full Text] [Related]
12. DWI Lesion Patterns in Cancer-Related Stroke--Specifying the Phenotype.
Schwarzbach CJ; Fatar M; Eisele P; Ebert AD; Hennerici MG; Szabo K
Cerebrovasc Dis Extra; 2015; 5(3):139-45. PubMed ID: 26648971
[TBL] [Abstract][Full Text] [Related]
13. D-dimer levels and cerebral infarction in critically ill cancer patients.
Ryu JA; Bang OY; Lee GH
BMC Cancer; 2017 Aug; 17(1):591. PubMed ID: 28854911
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated ischemic stroke is associated with elevated D-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer.
Kono T; Ohtsuki T; Hosomi N; Takeda I; Aoki S; Sueda Y; Ishihara K; Nakamura T; Yamawaki T; Matsumoto M
Geriatr Gerontol Int; 2012 Jul; 12(3):468-74. PubMed ID: 22233138
[TBL] [Abstract][Full Text] [Related]
15. MR-imaging pattern is not a predictor of occult atrial fibrillation in patients with cryptogenic stroke.
Vollmuth C; Stoesser S; Neugebauer H; Hansel A; Dreyhaupt J; Ludolph AC; Kassubek J; Althaus K
J Neurol; 2019 Dec; 266(12):3058-3064. PubMed ID: 31511980
[TBL] [Abstract][Full Text] [Related]
16. D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale.
Kim YD; Song D; Nam HS; Lee K; Yoo J; Hong GR; Lee HS; Nam CM; Heo JH
Thromb Haemost; 2015 Aug; 114(3):614-22. PubMed ID: 25994249
[TBL] [Abstract][Full Text] [Related]
17. Multiple Infarcts Are Associated With Long-Term Stroke Recurrence and All-Cause Mortality in Cryptogenic Stroke Patients.
Nezu T; Mukai T; Uemura J; Yamashita M; Kitano T; Wada Y; Yagita Y
Stroke; 2016 Sep; 47(9):2209-15. PubMed ID: 27462116
[TBL] [Abstract][Full Text] [Related]
18. Predictors of 30-day mortality and the risk of recurrent systemic thromboembolism in cancer patients suffering acute ischemic stroke.
Nam KW; Kim CK; Kim TJ; An SJ; Oh K; Mo H; Kang MK; Han MK; Demchuk AM; Ko SB; Yoon BW
PLoS One; 2017; 12(3):e0172793. PubMed ID: 28282388
[TBL] [Abstract][Full Text] [Related]
19. Association of ischemic lesion patterns on early diffusion-weighted imaging with TOAST stroke subtypes.
Kang DW; Chalela JA; Ezzeddine MA; Warach S
Arch Neurol; 2003 Dec; 60(12):1730-4. PubMed ID: 14676047
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of plasma (D)-dimer levels for cancer-related stroke: a 3-year retrospective study.
Guo YJ; Chang MH; Chen PL; Lee YS; Chang YC; Liao YC
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e249-54. PubMed ID: 24295603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
